Facebook
X
LinkedIn
ForwardFAAIS 2026 Annual Meeting
The 3-day conference will contain didactic and panel discussion regarding the published clinical data on these topics, so that physicians and their patients can make informed choices, as well as enhance patient care.
Target Audience
This activity is designed for physicians and nurses involved in the care of patients with allergy, asthma and immunologic diseases.
Learning Objectives
Upon completion of the educational activity, participants should be able to:
Jonathan A. Bernstein, MD – Emerging Treatments for Hives and Itch
Define the subtypes of chronic spontaneous urticaria (CSU).
Determine the current emerging therapeutic approaches for CSU.
Discuss updated JTF CSU Guidelines.
Diego J. Maselli, MD, FCCP, ATSF – Bronchiectasis: Inflammation, Mucus and Beyond
Explain the pathophysiology of bronchiectasis.
Discuss the utilization of airway clearance treatments.
Review the new paradigms of anti-inflammatoy therapies in bronchiectasis.
Hugh Windom, MD – Nuts and Bolts of Food OIT & SLIT
Recognize food allergy is a treatable condition.
Diagnose and select a treatment course for your food allergy patients.
Differentiate between food desensitization options currently available.
Jonathan A. Bernstein, MD - Approach to Evaluation and Treatment of Angioedema without Urticaria
Define potential underlying causes of angioedema.
Discuss current treatment recommendations for angioedema.
Describe emerging therapies for angioedema.
Amber N. Pepper, MD – Management of Asthma and Allergies in Pregnancy
Identify the options available for the treatment of rhinitis and asthma in pregnancy.
Analyze the safety of these different treatments in pregnant women.
Discuss how to choose the best treatment(s) for each patient.
Jacqueline Squire, MD – Adult Immunodeficiency
Discuss primary immunodeficiency diseases presenting in adulthood.
Identify causes of secondary immunodeficiency.
Review testing and treatment of immunodeficiency.
Amber N. Pepper, MD – Non-IgE Mediated Food Allergies
Describe diverse manifestations of food-mediated reactions.
Identify examples of non-IgE mediated reactions to food that can mimic food allergy.
Recognize when and how to utilize food allergy testing in the evaluation of food reactions.
Gregory A. Poland, MD, MATh, MACP, FIDSA, FRCP – The Future of Vaccines Today and Tomorrow
Discuss the current cultural and scientific issues surrounding vaccines in the US.
Evaluate new scientific advances in vaccinology: adversomics and individualized vaccinology.
Propose joint work across the intersections of vaccinology, immunology, and allergy.
Diego J. Maselli, MD, FCCP, ATSF – Assessment and Management of Comorbidities in Asthma
Review the impact of comorbid conditions in asthma outcomes.
Evaluate the evidence behind treating asthma comorbid conditions.
Andrew F. Alexis, MD, MPH – Treatment of Atopic Dermatitis Across All Skin Tones
Recognize clinical variations of atopic dermatitis across diverse skin tones.
Evaluate evidence-based treatment strategies for atopic dermatitis in patients of all skin types.
Discuss nuances in the management of atopic dermatitis across diverse skin tones.
Scott P. Commins, MD, PhD – The Potential Role of Environmental Aallergies in EoE
Define the clinical characteristics of Eosinophilic Esophagitis (EoE).
Identify relevant allergen testing in EoE.
Design clinical treatment and management strategies for EoE.
Mariana Castells, MD, PhD – Biologic and Chemotherapy Desensitizations
Recognize the phenotypes and endotypes of hypersensitivity reactions to chemotherapy and monoclonal antibodies.
Address risk stratification for desensitization through serum biomarkers, skin testing, and BAT.
Scott P. Commins, MD, PhD – Evaluation and Management of Alpha-Gal Syndrome
Recognize a clinical history consistent with alpha-gal syndrome & understand how to diagnose it.
Recognize the risk factors that may lead to a patient developing alpha-gal syndrome.
Discuss management options and proper avoidance diet for patients with alpha-gal syndrome.
Mariana Castells, MD, PhD – Practical Approach to MCAS
Recognize the presentation and diagnosis of mast cell activation syndromes including MCAS and HAT.
Evaluate the role of biomarkers and TPSAB1 genotyping.
Review management strategies and future options for mast cell activation disorders.
Dennis K. Ledford, MD, FAAAAI, FACAAI, LCP – What To Do When Biologics Do Not Work For Your Patients With Severe Asthma
Enable participants to assess likely causes of persistent symptoms after starting a biologic for asthma.
Provide treatment options when biologic therapy not optimally successful.
Commercial Support
There is no commercial support for this activity.
All of the relevant financial relationships listed for these individuals have been mitigated.
Disclosures
It is the policy of AKH Inc. to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The author must disclose to the participants any significant relationships with ineligible companies whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflicts of interest are mitigated by AKH prior to accreditation of the activity. AKH planners and reviewers have no relevant financial relationships to disclose.
Disclosure of Unlabeled Use and Investigational Product
This educational activity may include discussion of uses of agents that are investigational and/or unapproved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
This course is designed solely to provide the healthcare professional with information to assist in his/her practice and professional development and is not to be considered a diagnostic tool to replace professional advice or treatment. The course serves as a general guide to the healthcare professional, and therefore, cannot be considered as giving legal, nursing, medical, or other professional advice in specific cases. AKH Inc. specifically disclaim responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through participants misunderstanding of the content. If you would like to opt out from future communications from AKH please send an email to [email protected] with your information with "Opt Out" in the subject line.
Dorothy Caputo, MA BSN RN
Rebecca Lakofsky, BSN, RN
Andrew Alexis
Jonathan Bernstein, Professor of Medicine
Mariana Castells, MD, PhD
Scott Commins, MD, PhD
Denns Ledford, MD
Diego Maselli, MD, FCCP, ATSF
Amber Pepper, MD, Associate Professor of Medicine and Pediatrics, Director of USF Allergy/Immunology Clinical Research Unit
Gregory Poland, MD, MATh, FIDSA, MACP, FRCP (London)
Jacqueline Squire, MD, FAAAAI
Hugh Windom, MD
In support of improving patient care, this activity has been planned and implemented by AKH Inc., Advancing Knowledge in Healthcare and Florida Allergy, Asthma & Immunology Society. AKH Inc., Advancing Knowledge in Healthcare is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
This activity was planned by and for the healthcare team, and learners will receive 11.25 Interprofessional Continuing Education (IPCE) credit for learning and change.
Available Credit
- 11.25 AAPA Category 1 CME
AKH Inc., Advancing Knowledge in Healthcare has been authorized by the American Academy of Physician Associates (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 11.25 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation. - 11.25 MOC_ABIM Medical Knowledge
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 11.25 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
- 11.25 AMA PRA Category 1 Credit™
Physicians
AKH Inc., Advancing Knowledge in Healthcare designates this Live Activity for a maximum of 11.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. - 11.25 ANCC Contact Hours
Credit being awarded: 11.25 ANCC contact hours
- 11.25 Attendance
Credits: 11.25
- 11.25 AMA PRA Category 1 Credit™ Non-MD
Non-Physicians Seeking AMA Credit
AKH Inc., Advancing Knowledge in Healthcare designates this Live Activity for a maximum of 11.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Price
Criteria for Success
To obtain credit, you must complete the activity evaluation and claim credit based on your attendance. The Certificate of Completion is immediately available for download after submitting your evaluation. It will remain in your profile transcript for future retrieval if needed. It can be found under My Account > My Activities > Completed Activities.
If you have any questions, contact [email protected].